A de novo nonsense variant in the GRIA2 gene was observed in an ASD proband from the Autism Sequencing Consortium in De Rubeis et al., 2014, while a de novo missense variant in GRIA2 was observed in an ASD proband from a multiplex family from the ASD: Genomes to Outcome Study cohort in Yuen et al., 2017. Salpietro et al., 2019 reported heterozygous de novo GRIA2 variants in 28 unrelated patients with intellectual disability and neurodevelopmental abnormalities including autism spectrum disorder (ASD), Rett syndrome-like features, and seizures or developmental epileptic encephalopathy (DDE).
Molecular Function
This gene encodes a receptor for glutamate that functions as a ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA).
External Links
References
Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Synaptic, transcriptional and chromatin genes disrupted in autism.
Model Type:
Genetic
Model Genotype:
Homozygous
Mutation:
Targeted delection of Gria2 subunit.
Allele Type: Targeted (Knock Out)
Strain of Origin: Not Specified
Genetic Background: Not Specified
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Jackson Laboratory
Miniature post synaptic current amplitude: excitatory1
Decreased
Description: Decreased basal amplitude of mepsc's and no depression in mepsc amplitude in response to pda treatment in purkinje cells
Exp Paradigm: Whole-cell recordings of purkinje cells and chemical ltd induction with pda after transfection of mutant gria2 s880e construct
Description: Decreased cerebellar long term depression in purkinje cells after transfection of mutant gria2
Exp Paradigm: Whole-cell voltage clamp recordings in purkinje cell culture system after transfection of expression construct encoding gria2 k882a and gria2 s880e mutants
Miniature post synaptic current amplitude: excitatory1
Decreased
Description: Decreased basal amplitude of mepsc's and no depression in mepsc amplitude in response to pda treatment in purkinje cells
Exp Paradigm: Whole-cell recordings of purkinje cells and chemical ltd induction with pda
Description: Decreased cerebellar long term depression in purkinje cells
Exp Paradigm: Whole-cell voltage clamp recordings in purkinje cell culture system
Miniature post synaptic current amplitude: excitatory1
Abnormal
Description: Abnormal mepsc with no change in basal amplitude but no depression in response to pda
Exp Paradigm: Whole-cell recordings of purkinje cells and chemical ltd induction with pda after transfection of mutant gria2 k882a construct
Description: Decreased induction of long term depression in granule cell-purkinje cell pairs after transfection of mutant gria2
Exp Paradigm: Whole-cell voltage clamp recordings after induction with epscs in granule cell - purkinje cell pairs after transfection of expression construct encoding gria2 k882a mutants
Description: Decreased cerebellar long term depression induction in purkinje cells
Exp Paradigm: Whole-cell voltage clamp recordings after chemical induction and after transfection of k882a & s880e mutant gria2 constructs